Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Market capitalization

Market capitalization at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
$4.29B-64.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.76B+38.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.02B+2.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$3.97B+51.0%
United Therapeutics logo
United TherapeuticsUTHR
$25.99B+87.7%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Enterprise value$3.71B+21.5%
P/S209.3×-3,875×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0×0.0×
Current ratio18.6×-3.9×

Where this comes from

Computed from the period-end share price: $3.8B.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's market capitalization?
Crinetics Pharmaceuticals (CRNX) reported market capitalization of $3.8B in Q1 2026.
How has Crinetics Pharmaceuticals's market capitalization changed year-over-year?
Crinetics Pharmaceuticals's market capitalization increased by 21.9% year-over-year, from $3.12B to $3.8B.
What is the long-term trend for Crinetics Pharmaceuticals's market capitalization?
Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's market capitalization has grown at a 45.8% compound annual growth rate (CAGR), from $670.22M to $4.42B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.